Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]

Article

Abstract: Background: Cutaneous Leishmaniasis is a worldwide disease, endemic in 88 countries, that has shown

Palabras claves:

Autores:

Buitrago A., Díaz H., López M., Mosquera H., Muñoz G., PATRICIO LOPEZ -JARAMILLO, Rueda L.C., Rueda-Clausen C.F., Silva S.Y., Silva-Sieger F.A., Smith D.J., Vélez I.D.

Fuentes:

google

scopus